Ignite Creation Date:
2024-05-06 @ 8:59 AM
Last Modification Date:
2024-10-26 @ 12:08 PM
Study NCT ID:
NCT02874807
Status:
COMPLETED
Last Update Posted:
2019-06-13
First Post:
2016-08-17
Brief Title:
Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study
Sponsor:
University Hospital Basel Switzerland
Organization:
University Hospital Basel Switzerland
Organization Data
Organization:
University Hospital Basel Switzerland
Class:
OTHER
Study ID:
SAND study
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Basel Switzerland
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None